Defining the usefulness of high CD34+CD38low blast frequency in blood of adult AML patients - a pre-treatment biomarker of poor outcome to standard chemotherapy

    Project Details

    Short titleDefining the usefulness of high CD34+CD38low blast frequency in blood of adult AML patients - a pre-treatment biomarker of poor outcome to standard chemotherapy
    StatusFinished
    Effective start/end date1/04/16 → 31/05/20

    Funding

    • BLOODWISE